Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

Anticoagulants are a potential treatment for the thrombotic complications resulting from COVID-19. We aimed to determine the association between anticoagulant use and adverse outcomes among hospitalized patients with COVID-19. We used data from the COVID-19 International Collaborative Research Proje...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ya-Hui, Oh, In-Sun, Jeong, Han Eol, Platt, Robert W., Douros, Antonios, Shin, Ju-Young, Filion, Kristian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729259/
https://www.ncbi.nlm.nih.gov/pubmed/36506517
http://dx.doi.org/10.3389/fphar.2022.1034636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729259/
https://www.ncbi.nlm.nih.gov/pubmed/36506517
http://dx.doi.org/10.3389/fphar.2022.1034636

Ejemplares similares